Quality of life and pain in premenopausal women with major depressive disorder: The POWER Study

Health and Quality of Life Outcomes

Volumn 4, Issue , 2006, Pages

  Hartman, Jill M ^a   Berger, Ann ^a   Baker, Karen ^a   Bolle, Jacques ^a   Handel, Daniel ^a   Mannes, Andrew ^a   Pereira, Donna ^a   St Germain, Diane ^a   Ronsaville, Donna ^b   Sonbolian, Nina ^c   Torvik, Sara ^a,c   Calis, Karim A ^a   Phillips, Terry M ^d   Cizza, Giovanni ^b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c National Kidney Disease Education Program   (United States)

^d Ultramicro Analytical Immunochemistry Resource   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CALCITONIN GENE RELATED PEPTIDE; MINERAL; NEUROPEPTIDE; ORAL CONTRACEPTIVE AGENT; PSYCHOTROPIC AGENT; SUBSTANCE P; VITAMIN; ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; ANXIETY; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; INSOMNIA; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MEMORY DISORDER; PAIN; PAIN ASSESSMENT; PREMENOPAUSE; PREVALENCE; QUALITY OF LIFE; RATING SCALE; WELLBEING; BLOOD; BONE DENSITY; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; LONGITUDINAL STUDY; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PREMENOPAUSE; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; SUBSTANCE P;

EID: 33144486343     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-4-2     Document Type: Article

References (29)

1. Kessler RC, Berglund P, Demler O. Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
2. Wilson KG, Eriksson MY, D'Eon JL, Mikail SF, Emery PC: Major depression and insomnia in chronic pain. Clin J Pain 2002, 18:77-83.
3. Ciccone DS, Natelson BH: Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis. Psychosom Med 2003, 65:268-275.
4. Korszun A, Young EA, Engleberg NC, Brucksch CB, Greden JF, Crofford LA: Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. J Psychosom Res 2002, 52:439-443.
5. Alonso C, Coe CL: Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women. Health Psych 2001, 20:411-416.
6. Lydiard RB: Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psych 2001, 62:38-45.
7. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF: Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997, 69:153-160.
8. Gallagher RM, Verma S: Managing pain and comorbid depression: A public health challenge. Semin Clin Neuropsychiatry 1999, 4:203-220.
9. Carroll LJ, Cassidy JD, Co̊té P: Depression as a risk factor for onset of an episode of troublesome neck and low back pain. Pain 2004, 107:134-139.
10. Dworkin SF, Von Korff M, LeResche L: Multiple Pains and Psychiatric Disturbance: An Epidemiologic Investigatimon. Arch Gen Psychiatry 1990, 37:239-244.
11. Smith GR: The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, or pain. Gen Hosp Psychiatry 1992, 14:265-272.
12. Elliott TE, Renier CM, Palcher JA: Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med 2003, 4:331-339.
13. Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, Sebring N, Drinkard BE, Levy C. Reynolds JC, Csako G, Gold PW, Horne M, Cizza G: Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: Implications for greater cardiovascular risk. Metabolism 2005, 54:918-924.
14. Cleeland CS: Brief Pain Inventory - Short Form (BPI - SF) Houston, TX; 1994.
15. McCaffery M, Beebe A: Pain: Clinical Manual for Nursing Practice St Louis, MO: Mosby; 1989.
16. Casso D, Buist DS, Taplin S: Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004, 2:25.
17. Wang SJ, Fuh JL, Lu SR, Juang KD: Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 2001, 89:285-292.
18. Ware J E, Kosinski M, Gandek B: SF-36 Health Survey. Manual and Interpretation Guide Lincoln, RI: QualityMetric Incorporated; 1993. 2000
19. Ware JE, Kosinski M: SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version I Second edition. Lincoln, RI: QualityMetric Incorporated; 2001.
20. Castle PE, Phillips TM, Hildesheim A, Herrero P, Bratti MC, Rodriguez AC, Morera LA, Pfeiffer R, Hutchinson ML, Pinto LA, Schiffman M: Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography. Cancer Epidemiol Biomarkers Prev 2003, 12:1449-1456.
21. Ohayon MM, Schatzberg AF: Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003, 60:39-47.
22. Doll HA, Petersen SE, Stewart-Brown SL: Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res 2000, 8:160-170.
23. Van Houdenhove B, Neerinckx E, Onghena P, Vingerhoets A, Lysens R, Vertommen H: Daily hassles reported by chronic fatigue syndrome and fibromyalgia patients in tertiary care: a controlled quantitative and qualitative study. Psychother Psychosom 2002, 71:207-213.
24. Bomholt SF, Harbuz MS, Blackburn-Munro G, Blackburn-Munro RE: Involvement and role of the hypothalamo-pituitary-adrenal (HPA) stress axis in animal models of chronic pain and inflammation. Stress 2004, 7:1-14.
25. Marques-Deak A, Cizza G, Sternberg E: Brain-immune interactions and disease susceptibility. Mol Psychiatry 2005, 10:239-250.
26. Bondy B, Baghai TC, Minov C, Schule C, Schwarz MJ, Zwanzger P, Rupprecht R, Moller HJ: Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry 2003, 53:538-542.
27. Mathe AA Agren H, Lindstrom L, Theodorsson E: Increased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorder. Neurosci Lett 1994, 182:138-142.
28. Holsboer F, Barden N: Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17:187-205.
29. Cizza G, Mistry S, Eskandari F, Martinez P, Torvik S, Wesley R, Sternberg EM, Phillips TM: A group of 21 to 45 year old women with major depression exhibits greater plasma proinflammatory and lower anti-inflammatory cytokines. Potential implications for depression-induced osteoporosis and other medical consequences of depression. 86th Annual Meeting of the Endocrine Society, New Orleans, Louisiona, June 16-19, 2004.